Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1952 1
1953 2
1956 1
1960 1
1963 3
1964 2
1969 1
1973 1
1974 2
1976 1
1977 2
1978 1
1979 2
1980 5
1981 1
1982 2
1983 5
1984 5
1985 5
1986 6
1987 4
1988 7
1989 11
1990 8
1991 6
1992 13
1993 7
1994 11
1995 12
1996 14
1997 18
1998 12
1999 11
2000 22
2001 21
2002 14
2003 37
2004 28
2005 22
2006 47
2007 35
2008 47
2009 40
2010 55
2011 54
2012 66
2013 73
2014 103
2015 112
2016 110
2017 134
2018 127
2019 128
2020 154
2021 139
2022 141
2023 149
2024 46

Text availability

Article attribute

Article type

Publication date

Search Results

1,845 results

Results by year

Filters applied: . Clear all
Proximity search should include two or more words. Proximity operator ignored :~0
Page 1
Immunotherapy for glioma: Current management and future application.
Xu S, Tang L, Li X, Fan F, Liu Z. Xu S, et al. Cancer Lett. 2020 Apr 28;476:1-12. doi: 10.1016/j.canlet.2020.02.002. Epub 2020 Feb 7. Cancer Lett. 2020. PMID: 32044356 Free article. Review.
Gliomas are intrinsic brain tumors that originate from neuroglial progenitor cells. Conventional therapies, including surgery, chemotherapy, and radiotherapy, have achieved limited improvements in the prognosis of glioma patients. ...Moreover, several drugs that hav …
Gliomas are intrinsic brain tumors that originate from neuroglial progenitor cells. Conventional therapies, including surgery, chemot …
Primary brain tumours in adults.
van den Bent MJ, Geurts M, French PJ, Smits M, Capper D, Bromberg JEC, Chang SM. van den Bent MJ, et al. Lancet. 2023 Oct 28;402(10412):1564-1579. doi: 10.1016/S0140-6736(23)01054-1. Epub 2023 Sep 19. Lancet. 2023. PMID: 37738997 Review.
Resection as extensive as is safely possible is the cornerstone of treatment in most gliomas, and is now also recommended early in the treatment of patients with radiological evidence of histologically low-grade tumours. For the adult-type diffuse glioma, standard of ca …
Resection as extensive as is safely possible is the cornerstone of treatment in most gliomas, and is now also recommended early in the treat …
Neurofibromatosis type 1 (NF1): diagnosis and management.
Ferner RE, Gutmann DH. Ferner RE, et al. Handb Clin Neurol. 2013;115:939-55. doi: 10.1016/B978-0-444-52902-2.00053-9. Handb Clin Neurol. 2013. PMID: 23931823 Review.
Advances in molecular biology and mouse models of disease have enhanced our understanding of the pathogenesis of NF1 complications and facilitated targeted therapy. Progress has been made in developing robust clinical and radiological outcome measures and clinical trials a …
Advances in molecular biology and mouse models of disease have enhanced our understanding of the pathogenesis of NF1 complications and facil …
Glioblastoma multiforme: Pathogenesis and treatment.
Alifieris C, Trafalis DT. Alifieris C, et al. Pharmacol Ther. 2015 Aug;152:63-82. doi: 10.1016/j.pharmthera.2015.05.005. Epub 2015 May 2. Pharmacol Ther. 2015. PMID: 25944528 Review.
A deeper understanding of the pathogenesis of these tumors has presented opportunities for newer therapies to evolve and an expectation of better control of this disease. Lately, efforts have been made to investigate tumor resistance, which results from complex alternate s …
A deeper understanding of the pathogenesis of these tumors has presented opportunities for newer therapies to evolve and an expectati …
Management of epilepsy in brain tumor patients.
van der Meer PB, Taphoorn MJB, Koekkoek JAF. van der Meer PB, et al. Curr Opin Oncol. 2022 Nov 1;34(6):685-690. doi: 10.1097/CCO.0000000000000876. Epub 2022 Jul 16. Curr Opin Oncol. 2022. PMID: 35838207 Free PMC article. Review.
A beneficial effect of antitumor treatment (i.e. surgery, radiotherapy, and chemotherapy) on seizure control has mainly been demonstrated in low-grade glioma. AED prophylaxis in seizure-naive BTRE patients is not recommended, but AED treatment should be initiated after a f …
A beneficial effect of antitumor treatment (i.e. surgery, radiotherapy, and chemotherapy) on seizure control has mainly been demonstrated in …
Glioma epigenetics: From subclassification to novel treatment options.
Gusyatiner O, Hegi ME. Gusyatiner O, et al. Semin Cancer Biol. 2018 Aug;51:50-58. doi: 10.1016/j.semcancer.2017.11.010. Epub 2017 Nov 21. Semin Cancer Biol. 2018. PMID: 29170066 Review.
Furthermore, in adult glioblastoma patients epigenetic silencing of the DNA repair gene MGMT by promoter methylation is predictive for benefit from alkylating agent therapy. These epigenetic alterations are used as biomarkers and play a central role for classification of g …
Furthermore, in adult glioblastoma patients epigenetic silencing of the DNA repair gene MGMT by promoter methylation is predictive for benef …
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults.
Wen PY, van den Bent M, Youssef G, Cloughesy TF, Ellingson BM, Weller M, Galanis E, Barboriak DP, de Groot J, Gilbert MR, Huang R, Lassman AB, Mehta M, Molinaro AM, Preusser M, Rahman R, Shankar LK, Stupp R, Villanueva-Meyer JE, Wick W, Macdonald DR, Reardon DA, Vogelbaum MA, Chang SM. Wen PY, et al. J Clin Oncol. 2023 Nov 20;41(33):5187-5199. doi: 10.1200/JCO.23.01059. Epub 2023 Sep 29. J Clin Oncol. 2023. PMID: 37774317
PURPOSE: The Response Assessment in Neuro-Oncology (RANO) criteria for high-grade gliomas (RANO-HGG) and low-grade gliomas (RANO-LGG) were developed to improve reliability of response assessment in glioma trials. Over time, some limitations of these criteria were identifie …
PURPOSE: The Response Assessment in Neuro-Oncology (RANO) criteria for high-grade gliomas (RANO-HGG) and low-grade gliomas (RANO-LGG) were d …
Management of pediatric low-grade glioma.
de Blank P, Bandopadhayay P, Haas-Kogan D, Fouladi M, Fangusaro J. de Blank P, et al. Curr Opin Pediatr. 2019 Feb;31(1):21-27. doi: 10.1097/MOP.0000000000000717. Curr Opin Pediatr. 2019. PMID: 30531227 Free PMC article. Review.
PURPOSE OF REVIEW: Pediatric low-grade gliomas (pLGGs) have been treated with similar therapies for the last 30 years. Recent biological insights have allowed a new generation of targeted therapies to be developed for these diverse tumors. ...However, late effects o …
PURPOSE OF REVIEW: Pediatric low-grade gliomas (pLGGs) have been treated with similar therapies for the last 30 years. Recent biologi …
Childhood brain tumors: current management, biological insights, and future directions.
Pollack IF, Agnihotri S, Broniscer A. Pollack IF, et al. J Neurosurg Pediatr. 2019 Mar 1;23(3):261-273. doi: 10.3171/2018.10.PEDS18377. J Neurosurg Pediatr. 2019. PMID: 30835699 Free PMC article. Review.
Likewise, high-grade glioma, which for decades was considered a single high-risk entity, is now known to comprise multiple subsets of tumors that differ in terms of patient age, tumor location, and prognosis. ...Conversely, the majority of pilocytic astrocytomas appear to …
Likewise, high-grade glioma, which for decades was considered a single high-risk entity, is now known to comprise multiple subsets of …
Immunotherapy: a promising approach for glioma treatment.
Yasinjan F, Xing Y, Geng H, Guo R, Yang L, Liu Z, Wang H. Yasinjan F, et al. Front Immunol. 2023 Sep 7;14:1255611. doi: 10.3389/fimmu.2023.1255611. eCollection 2023. Front Immunol. 2023. PMID: 37744349 Free PMC article. Review.
Despite two decades of relentless pursuit in exploring novel therapeutic approaches for GBM, there is limited progress in improving patients' survival outcomes. ...There are four main types of immunotherapies for gliomas, immune checkpoint blockades, chimeric antigen recep …
Despite two decades of relentless pursuit in exploring novel therapeutic approaches for GBM, there is limited progress in improving p …
1,845 results